About
Contact
Subscribe
e-Edition

Make Home Page

Dashboard
Logout

- My Account
- Dashboard
- Profile
- Saved items
- Logout

Facebook
Twitter

- Site search

Home
News
Sports
- Local Sports
- National Sports
Business
Opinion
A & E
Life
Features & Magazines
Classifieds
Weather
Obituaries
Parcel Pickup

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Dare Bioscience, Inc. - Common Stock (NQ:DARE)

1.295 -0.105 (-7.50%)

Streaming Delayed Price Updated: 3:43 PM EDT, Mar 19, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Dare Bioscience, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

May 21, 2024

Via Benzinga

Bayer Highlights Detailed Data From Twin Late-Stage Trials On Experimental Menopause Candidate, Seeks Regulatory Approval ↗

May 17, 2024

Bayer to present detailed Phase 3 OASIS 1 and 2 study results showing elinzanetant significantly reduces moderate to severe menopausal vasomotor symptoms compared to placebo.

Via Benzinga

DARE Stock Earnings: Dare Bioscience Misses EPS, Beats Revenue for Q1 2024 ↗

May 14, 2024

DARE stock results show that Dare Bioscience missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.

Via InvestorPlace

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

April 30, 2024

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

April 25, 2024

Via Benzinga

Recap: Dare Bioscience Q4 Earnings ↗

March 28, 2024

Via Benzinga

Dare Bioscience Earnings Preview ↗

March 27, 2024

Via Benzinga

Earnings Outlook For Dare Bioscience ↗

November 08, 2023

Via Benzinga

Why H&E Equipment Services Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

April 30, 2024

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

April 24, 2024

Via Benzinga

Earnings Outlook For Dare Bioscience ↗

August 09, 2023

Via Benzinga

Recap: Dare Bioscience Q1 Earnings ↗

May 11, 2023

Via Benzinga

Earnings Outlook For Dare Bioscience ↗

May 10, 2023

Via Benzinga

Earnings Preview: Dare Bioscience ↗

March 29, 2023

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

April 17, 2024

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

March 28, 2024

Via Benzinga

DARE Stock Earnings: Dare Bioscience Beats EPS, Beats Revenue for Q4 2023 ↗

March 28, 2024

DARE stock results show that Dare Bioscience beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023.

Via InvestorPlace

First Lady Jill Biden Unveils $100M In Federal Funding To Support R&D - Watch Out for These Women Health Stocks ↗

February 21, 2024

Jill Biden announces $100 million in federal funding for women's health research, addressing underfunding and lack of awareness. ARPA-H Sprint for Women's Health aims to promote innovative solutions.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

February 01, 2024

It's time to get into the biggest pre-market stock movers as we check out all of the hottest news happening on Thursday morning!

Via InvestorPlace

Earnings Scheduled For March 28, 2024 ↗

March 28, 2024

Companies Reporting Before The Bell • Universal Stainless (NASDAQ:USAP) is expected to report quarterly earnings at $0.32 per share on revenue of $78.65 million.

Via Benzinga

Daré Bioscience Highlights Efficacy Data From Treatment Candidate For Painful Menstruation ↗

December 20, 2023

Daré Bioscience Inc (NASDAQ: DARE) announced topline results from the Phase 1 DARE-PDM1-001 study evaluating the pharmacokinetics (PK), safety, and exploratory efficacy of DARE-PDM1 an investigational...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

December 20, 2023

Via Benzinga

FDA Gives Nod To Daré Bioscience's Trial Of Non-Hormonal Treatment For Dyspareunia, Seeks Additional Funding ↗

December 07, 2023

Daré Bioscience Inc (NASDAQ: DARE) announced that the FDA has cleared its investigational new drug (IND) application for DARE-VVA1 as a non-hormonal treatment option for moderate to severe dyspareunia,...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

December 07, 2023

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

October 16, 2023

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

September 20, 2023

Via Benzinga

Stocks That Hit 52-Week Lows On Monday ↗

July 31, 2023

On Monday, 27 stocks hit new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

July 21, 2023

On Friday, 54 companies hit new 52-week lows.

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

July 17, 2023

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

April 03, 2023

We're starting off the week with a breakdown of the biggest pre-market stock movers worth keeping an eye on Monday morning!

Via InvestorPlace

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sections

News
Sports
Opinion
Photo Galleries
Videos
Local Events
Classifieds
Obituaries

Services

About
Contact
Personnel
Advertise
Subscription Services
Promote Your Event
Dealer Locations
Email Alerts
Submission Forms

Contact Information

chroniclejournal.com
75 S. Cumberland Street
Thunder Bay, ON P7B 1A3
Phone: 807 343 6200
Email: circulation@chroniclejournal.com

Facebook
Twitter

Browser Compatibility

Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:

Microsoft Edge Google Chrome Firefox

Dare Bioscience, Inc. - Common Stock (NQ:DARE)

All News about Dare Bioscience, Inc. - Common Stock

Sections

Services

Contact Information

Follow Us